光大证券晨会速递-20250820

Group 1: Company Research - Longbai Group (002601.SZ) reported steady growth in titanium dioxide production and sales in H1 2025, with improved profitability in iron-based products and new energy materials. The forecast for net profit attributable to shareholders for 2025-2027 is 2.957 billion, 3.367 billion, and 3.753 billion yuan respectively, maintaining a "buy" rating [2] - Sinopec Oilfield Service (600871.SH/1033.HK) achieved total operating revenue of 37.05 billion yuan in H1 2025, a year-on-year increase of 0.6%, and a net profit of 490 million yuan, up 9.0%. The projected net profit for 2025-2027 is 909 million, 1.099 billion, and 1.315 billion yuan, maintaining an "increase" rating for both A and H shares [3] - Hualing Steel (000932.SZ) reported a net profit attributable to shareholders of 4.012 billion yuan for 2025, marking a significant recovery in the steel industry. The profit forecasts for 2025-2027 have been raised to 4.012 billion, 4.373 billion, and 4.760 billion yuan, maintaining an "increase" rating [4] - Shenghong Co., Ltd. (300693.SZ) reported a revenue of 1.362 billion yuan in H1 2025, a decrease of 4.79%, with a net profit of 158 million yuan, down 12.91%. The forecast for net profit for 2025-2027 is 490 million, 613 million, and 745 million yuan, maintaining a "buy" rating [5] - Huada Technology (002185.SZ) achieved revenue of 7.780 billion yuan in H1 2025, a year-on-year increase of 15.81%, with a net profit of 226 million yuan, up 1.68%. The projected net profit for 2025-2027 is 994 million, 1.380 billion, and 1.601 billion yuan, maintaining an "increase" rating [6] - Xtep International (1368.HK) reported a revenue increase of 7.1% and a net profit increase of 21.5% in H1 2025. The forecast for net profit for 2025-2027 is 0.49, 0.55, and 0.60 yuan per share, maintaining a "buy" rating [7] - Gilead Sciences-B (1672.HK) reported a revenue of 0.01 billion yuan in H1 2025, with a net loss of 88 million yuan. The forecast for net profit for 2025-2027 is -421 million, -414 million, and -344 million yuan, maintaining a "buy" rating [9] - Aimeike (300896.SZ) faced pressure in H1 2025 due to intensified competition in the medical beauty industry, with a revised net profit forecast of 1.624 billion, 1.818 billion, and 2.026 billion yuan for 2025-2027, maintaining a "buy" rating [10] Group 2: Industry Insights - The titanium dioxide supply is currently relaxed, leading to intensified price competition in the industry [2] - The oil and gas sector is experiencing fluctuations in prices, impacting the overall performance of companies like Sinopec Oilfield Service [3] - The steel industry is witnessing a profit recovery, attributed to the reduction of internal competition [4] - The energy storage business is under short-term pressure, while the AIDC business shows significant growth potential [5] - The semiconductor industry is expected to benefit from a recovery in demand, positively impacting companies like Huada Technology [6] - The sportswear market is seeing growth driven by the main brand and collaboration with other brands like Saucony [7] - The pharmaceutical industry is focusing on differentiated product pipelines, particularly in metabolic disease treatments [9] - The medical beauty industry is facing challenges due to increased competition and a sluggish consumer environment [10]